Literature DB >> 26613957

IRF5 and IRF8 modulate the CAL-1 human plasmacytoid dendritic cell line response following TLR9 ligation.

Folkert Steinhagen1,2, Luis G Rodriguez1, Debra Tross1, Poonam Tewary1, Christian Bode1,2, Dennis M Klinman1.   

Abstract

Synthetic oligonucleotides (ODNs) containing CpG motifs stimulate human plasmacytoid dendritic cells (pDCs) to produce type-1 interferons (IFNs) and proinflammatory cytokines. Previous studies demonstrated that interferon regulatory factors (IRFs) play a central role in mediating CpG-induced pDC activation. This work explores the inverse effects of IRF5 and IRF8 (also known as IFN consensus sequence-binding protein) on CpG-dependent gene expression in the human CAL-1 pDC cell line. This cell line shares many of the phenotypic and functional properties of freshly isolated human pDCs. Results from RNA interference and microarray studies indicate that IRF5 upregulates TLR9-driven gene expression whereas IRF8 downregulates the same genes. Several findings support the conclusion that IRF8 inhibits TLR9-dependent gene expression by directly blocking the activity of IRF5. First, the inhibitory activity of IRF8 is only observed when IRF5 is present. Second, proximity ligation analysis shows that IRF8 and IRF5 colocalize within the cytoplasm of resting human pDCs and cotranslocate to the nucleus after CpG stimulation. Taken together, these findings suggest that IRF5 and IRF8, two transcription factors with opposing functions, control TLR9 signaling in human pDCs. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  CpG oligonucleotide; Dendritic cell; IRF8, IRF5; TLR9

Mesh:

Substances:

Year:  2015        PMID: 26613957      PMCID: PMC6385590          DOI: 10.1002/eji.201545911

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity.

Authors:  Sabira Mohammed; Nalanda S Vineetha; Shirley James; Jayasekharan S Aparna; Manendra Babu Lankadasari; Takahiro Maeda; Abhirupa Ghosh; Sudipto Saha; Quan-Zhen Li; Sarah Spiegel; Kuzhuvelil B Harikumar
Journal:  FASEB J       Date:  2020-01-23       Impact factor: 5.191

2.  B Cell-Intrinsic Role for IRF5 in TLR9/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation.

Authors:  Saurav De; Baohong Zhang; Tiffany Shih; Sukhwinder Singh; Aaron Winkler; Robert Donnelly; Betsy J Barnes
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

Review 3.  Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.

Authors:  Dóra Bencze; Tünde Fekete; Kitti Pázmándi
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

Review 4.  Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.

Authors:  Nicholas Stoy
Journal:  Front Immunol       Date:  2021-04-07       Impact factor: 7.561

5.  Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.

Authors:  Kwan T Chow; Courtney Wilkins; Miwako Narita; Richard Green; Megan Knoll; Yueh-Ming Loo; Michael Gale
Journal:  J Immunol       Date:  2018-10-08       Impact factor: 5.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.